Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients Jan 8, 2024 07:30AM
Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Update Nov 13, 2023 04:21PM
Orchestra BioMed to Present at Upcoming Investor Conferences Nov 9, 2023 04:42PM
Orchestra BioMed (OBIO) Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT Sep 19, 2023 07:30AM
Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for the Treatment of Hypertension in Pacemaker Patients Sep 19, 2023 07:30AM


Sep 6, 2023 05:02PM Motus GI Holdings (MOTS) Appoints Scott Durbin to its Board
Sep 6, 2023 05:00PM Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors
Aug 10, 2023 04:34PM Orchestra BioMed Reports Second Quarter 2023 Financial Results and Provides Business Update
Aug 8, 2023 08:30AM Orchestra BioMed (OBIO) Granted FDA Approval of IDE for U.S. Pivotal Study of Virtue Sirolimus AngioInfusion Balloon
Aug 8, 2023 08:30AM Orchestra BioMed™ Granted FDA Approval of IDE for U.S. Pivotal Study of Virtue® Sirolimus AngioInfusion Balloon™ in Patients with Coronary In-Stent Restenosis
Aug 8, 2023 08:30AM Orchestra BioMed™ Granted FDA Approval of IDE for U.S. Pivotal Study of Virtue® Sirolimus AngioInfusion Balloon™ in Patients with Coronary In-Stent Restenosis
Jun 26, 2023 08:00AM Orchestra BioMed Set to Join Russell 3000® and other FTSE Russell Indexes
Jun 7, 2023 08:31AM Orchestra BioMed (MOTS) Appoints Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor as Chief Financial Officer
Jun 7, 2023 08:30AM Orchestra BioMed Appoints Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor as Chief Financial Officer
Jun 1, 2023 08:00AM Orchestra BioMed to Present at the Jefferies Global Healthcare Conference
May 12, 2023 09:15AM Orchestra BioMed Reports First Quarter 2023 Financial Results and Provides Business Update